Getting to Know Pfizer’s New Chief Medical Officer Aida Habtezion
The Facts About Pfizer and BioNTech’s COVID-19 Vaccine
COVID-19 SCIENTIFIC RESOURCES
Know the Mutational Status of Your Cancer
Find a Trial
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
One Year Later: What We Have Learned
VISIT OUR COVID-19 HUB
Latest News
Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has extended the priority review period for the New Drug Application (NDA) for abrocitinib for the treatment of adults and adolescents with moderate to severe atopic dermatitis. The Prescription Drug User Fee Act (PDUFA) goal date has been extended three months to early Q3 2021. The FDA has also extended the review period for the Supplemental New Drug Applications (sNDAs) for XELJANZ ® / XELJANZ ® XR (…